ESMO Breast Cancer 2026 Highlights: SERENA-6 - Quiz - MDSpire

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

June 26, 2026

Dana-Farber

Share

Original Source(s)

Dana-Farber

ESMO Breast Cancer 2026 Highlights: SERENA-6

June 26, 2026

Related Content

Jama Network Open

Immunohistochemistry vs Molecular Breast Cancer Subtyping Among African Populations

by Shahin Sayed, Li Feng, Hela Koka, Manel Haj Mansour, Difei Wang, Maria Brown, Kristine Jones, Margaret Maina, Veronica Ngundo, Alfred Mburu Githuka, Zaitun Ajuoga, Shaoqi Fan, Amber N. Hurson, Xing Hua, Petra Lenz, Rosemary Wangari Kamau, Beryl Akinyi Ooro, Francis Makokha, Stefan Ambs, Aaron M. Rozeboom, Amy Hutchinson, Belynda Hicks, Mustapha Abubakar, Xiaohong R. Yang
October 12, 2026

Hemasphere

Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology

by Mirsada Čaušević, Robbie Loewith, Siniša Volarević
September 25, 2026

Journal Of Surgical Oncology

Association of Adjuvant Radiotherapy De-Escalation With Outcomes Following Oncoplastic Breast-Conserving Surgery